BUSINESS

• [Data] Sales of Fuso's Mainstay Products in FY2011
  June 19, 2012

• [Data] Sales of ASKA's Mainstay Products in FY2011
  June 19, 2012

• [Data] Sales of Nippon Chemiphar's Mainstay Products in FY2011
  June 19, 2012

• [Data] Sales of Wakamoto's Mainstay Products in FY2011
  June 19, 2012

• [Data] Sales of Torii’s Mainstay Products in FY2011
  June 19, 2012

• Merck of Germany Considers Entry into Japanese Biosimilars Market
  June 18, 2012

• Pharmacists Predict Further Use of Mucosta Generics: Survey
  June 18, 2012

• Asklep to Establish Subsidiary in Taiwan, Buffing Up CRO Business in Asia
  June 15, 2012

• Antiallergic Agent S-555739 Shows Efficacy in Combination Therapy in PIIb Study: Shionogi
  June 15, 2012

• Sales of Januvia, Cervarix Exceed 50 Billion Yen in 2 Years since Launch
  June 15, 2012

• DPP-4 Inhibitors Surged, RA Treatments Maintained Strong Growth in FY2011
  June 15, 2012

• Top 100 Products in FY2011: Pronounced Growth for ARB Combinations with Declining Sales of Monodrugs
  June 15, 2012

• Sanofi, Hisamitsu to Form JV for Allergy-Related OTCs, Seen Eyeing Allegra OTC Launch
  June 14, 2012

• Janssen Pharmaceutical to Enlarge Plant Expecting 2.7 Times Current Shipping Volume
  June 14, 2012

• Astellas to Collaborate with DNDi on Drug Discovery for Tropical Diseases
  June 14, 2012

• MTPC to Launch Tenelia in Sept., Expecting to Become a Growth Driver: President Tsuchiya
  June 14, 2012

• Midazolam is Most Used Sedative in Terminal Care: Doctor Survey
  June 13, 2012

• Japan Vaccine to Develop, Supply All Vaccines Needed in Japan by 2020
  June 13, 2012

• Astellas Launches Dificlir in Europe
  June 13, 2012

• Sanofi-Aventis Files NDA for GLP-1 Receptor Agonist Lixisenatide in Japan
  June 13, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 657
• 658
• 659
• 660
• 661
• 662
• 663
• 664
• 665
• …
• Next ›
• 最終 »